Matti Sällberg
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine (NCT05685953) | Matti Sällberg | 2023-02-08 |
Track Matti Sällberg automatically
Every clearance here is in the API, with alerts when new ones post.